Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT
0.88% (1D)
| Bid | 3.95 |
| Market Cap | 49.72M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -19.88M |
| EPS (ttm) | -1.78 |
| PE Ratio (ttm) | -2.59 |
| Forward PE | -2.54 |
| Analyst | Buy |
| Ask | 4.9 |
| Volume | 71,590 |
| Avg. Volume (20D) | 252,164 |
| Open | 4.55 |
| Previous Close | 4.57 |
| Day's Range | 4.25 - 4.69 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.59 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 days ago
-3.99%
Lantern Pharma shares are trading lower. The compa...
Unlock content with
Pro Subscription
2 weeks ago
+10.72%
Lantern Pharma shares are trading higher after the company announced early enrollment in Japan for lung cancer.
2 months ago · businesswire.com
Lantern Pharma's LP-184 Shows Promising In Vivo Activity in Atypical Teratoid Rhabdoid Tumors (ATRT) at SNO Pediatric Conference, Further Validating Rare Pediatric Disease Designation and Pathway to Clinical TrialsDALLAS--(BUSINESS WIRE)--ATRT data presented at SNO Pediatric 2025.